Image may differ
AESKULISA®
Reference:
6073
Designation:
Measles Virus IgM
Intended use:

The AESKULISA® Measles Virus IgG and IgM are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Measles virus. The AESKULISA® Measles Virus IgM supports the detection of acute infections. The AESKULISA® Measles Virus IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The AESKULISA® Measles Virus IgG is also used to detect intrathecally produced antibodies in cerebrospinal fluid. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made in consideration of all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgM
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Purified and inactivated measles virus
Edmonston strain
AESKULISA®

6073

Measles Virus IgM

Image may differ
Intended use:

The AESKULISA® Measles Virus IgG and IgM are qualitative and quantitative immunoassays for the detection of human IgG and IgM antibodies in serum or plasma against Measles virus. The AESKULISA® Measles Virus IgM supports the detection of acute infections. The AESKULISA® Measles Virus IgG allows the confirmation of pathogen contact and supports the determination of the immune status. The AESKULISA® Measles Virus IgG is also used to detect intrathecally produced antibodies in cerebrospinal fluid. The results can only be interpreted in conjunction with the clinical picture. A diagnosis should not be based solely on the results of the test performed, but should always be made in consideration of all clinical and laboratory findings. Further tests should be carried out for confirmation. AESKULISA® immunoassays are suitable for use by healthcare professionals with appropriate professional training in the use of in vitro diagnostics.

Method:
ELISA
Conjugate:
IgM
Analysis:
Qualitative
,
Quantitative
Cut Off:
Cut-off control
Measurement range:
Kit-specific
QC certificate
Provisions:
1 x 96
Kit-Configuration:
Single
Number of antigens:
1
Registration:
CE marking
Coated Antigens:
Purified and inactivated measles virus
Edmonston strain
Downloads
All related documents and information clearly summarized

Instructions for Use

Safety Data Sheet